Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Jonathan G. Drachman currently holds 5,415 shares of Neoleukin Therapeutics, Inc. (NLTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jonathan G. Drachman has been a net seller of NLTX stock. They have purchased $3.4M and sold $4.1M worth of shares.
Jonathan G. Drachman's most recent insider trade was on Mar 11, 2024, when they sold 5,531 shares at $0.00 per share.
Jonathan G. Drachman serves as Executive at Neoleukin Therapeutics, Inc. (NLTX). They have executed 64 insider transactions totaling $7.4M over their tenure at the company.
Jonathan G. Drachman holds the position of Executive at Neoleukin Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 12 years and currently hold a stake valued at $0.
Jonathan G. Drachman has shown a selling trading pattern, with $3.4M in total purchases and $4.1M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Jonathan G. Drachman was on Dec 20, 2019, when they purchased $1000.0K worth of NLTX shares. This transaction involved 119,047 shares at $8.40 per share.
Jonathan G. Drachman currently owns 5,415 shares of Neoleukin Therapeutics, Inc. (NLTX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Jonathan G. Drachman's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Jonathan G. Drachman has 64 Form 4 filings on record as an insider at Neoleukin Therapeutics, Inc..
Set alerts for Jonathan G. Drachman and 40,000+ other insiders.